Acusphere, Inc.
Contrast imaging and drug delivery technologies.
(NASDAQ: ACUS)
Alimera Sciences, Inc.
Therapeutics for degenerative eye diseases.
Ascenta Therapeutics, Inc.
Innovative therapeutics for cancer.
Cellective Therapeutics, Inc.
Monoclonal antibody therapies for cancer.
Acquired by MedImmune
Corixa Corporation
Developer of immunotherapeutics.
Acquired by GlaxoSmithKline
Coulter Pharmaceutical, Inc.
Monoclonal antibodies for the treatment of cancer.
Acquired by Corixa
CV Therapeutics, Inc.
Drugs for chronic cardiovascular disease.
(NASDAQ: CVTX)
diaDexus, Inc.
Genetic biomarkers for early detection of disease.
Dynavax Technologies Corporation
DNA based therapeutics.
(NASDAQ: DVAX)
La Jolla Pharmaceuticals Company
Therapeutics for autoimmune disease.
(NASDAQ: LJPC)
Prestwick Pharmaceuticals, Inc.
Therapeutics for the central nervous system disorders.
Seattle Genetics, Inc.
Monoclonal antibody-based therapeutics.
(NASDAQ: SGEN)
SGX Pharmaceuticals
Discovery, development and commercialization of innovative cancer therapeutics.
(NASDAQ: SGXP)
Somaxon Pharmaceuticals, Inc.
Specialty pharmaceutical products to treat psychiatric and related conditions.
(NASDAQ: SOMX)
Vical, Inc
Gene-based pharmaceuticals.
(NASDAQ: VICL)
